Rajendiran Saravanan, Krishnan B, Deepthy M S
Department of Dentistry, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), #8, 8th cross street, Bharathi Nagar, Lawspet Post, Puducherry, 605008 India.
Department of Biostatistics, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry, India.
J Maxillofac Oral Surg. 2024 Feb;23(1):56-67. doi: 10.1007/s12663-023-02011-5. Epub 2023 Sep 16.
The proponents of local route of Dexamethasone (DXM) administration for impacted mandibular 3rd molar (MM3) surgeries claim advantages over the traditional systemic routes. This systematic review and meta-analysis were aimed to determine whether the route of perioperative administration of DXM influences the inflammatory outcomes of MM3 surgeries.
An electronic database search over a 25 year period of randomised trials of DXM in MM3 surgeries was conducted. The mean differences or standardised mean differences were extracted and pooled using the fixed or random-effects model.
Of the sixteen selected trials, four were considered for a meta-analysis. There were no statistically significant differences in the inflammatory outcomes between the local and systemic routes of DXM.
The claimed advantages of the local route of DXM do not appear to be scientifically valid. Clinical trials supported with DXM plasma measurements are needed to confirm the absence of a systemic effect when DXM is administered locally.
地塞米松(DXM)局部给药用于下颌阻生第三磨牙(MM3)手术的支持者声称,该给药方式比传统全身给药途径更具优势。本系统评价和荟萃分析旨在确定围手术期DXM给药途径是否会影响MM3手术的炎症结局。
对25年间关于DXM用于MM3手术的随机试验进行电子数据库检索。使用固定效应或随机效应模型提取并汇总平均差或标准化平均差。
在16项入选试验中,4项被纳入荟萃分析。DXM局部给药和全身给药途径之间的炎症结局无统计学显著差异。
DXM局部给药所宣称的优势似乎并无科学依据。需要进行DXM血浆测量支持的临床试验,以证实局部应用DXM时不存在全身效应。